For kratom users facing workplace drug testing, the question of whether kratom shows up on a drug screen is understandably a priority concern. The short answer: standard drug tests do not test for kratom. However, specialized kratom-specific assays do exist and are occasionally used. This guide fromPureCraft CBDcovers everything you need to know — from standard 5-panel screens to specialized alkaloid detection.
Kratom alkaloids (mitragynine and 7-hydroxymitragynine) are not included in any standard multi-panel drug test.Despite kratom's partial agonism at opioid receptors, its alkaloids are structurally distinct from the opiates and opioids that appear on standard opiate panels. A 2019 study published in the Journal of Analytical Toxicology confirmed that standard immunoassay drug screens do not reliably detect mitragynine, even at high doses.
While kratom doesn't appear on standard panels, specialized tests do exist:
These specialized tests are rarely deployed in routine employment screening. They are more commonly used in forensic toxicology, research settings, clinical monitoring programs, and law enforcement investigations.
|
Test Type |
Detected Alkaloids |
Occasional Use |
Heavy Use |
|
Urine |
Mitragynine, 7-OH-mitragynine, metabolites |
Up to 5–7 days |
Up to 9 days |
|
Blood |
Mitragynine |
Up to 24 hours |
Up to 2–3 days |
|
Hair follicle |
Mitragynine |
Up to 90 days |
Up to 90 days |
|
Saliva |
Mitragynine |
Up to 24 hours |
Up to 48 hours |
No — published research does not support this. Kratom's alkaloids are structurally different enough from opiates/opioids that standard immunoassay screens do not produce false positives. A 2019 journal study confirmed no reliable cross-reactivity at standard screening thresholds.
The Department of Defense has warned service members against kratom use. Military testing panels are more comprehensive than civilian panels and kratom testing may be specifically included. Service members should treat kratom as prohibited.
The best approach is time — abstaining from use as far in advance as possible. Hydration and moderate exercise support general metabolic clearance, but there is no scientifically validated method to accelerate kratom elimination beyond normal physiology.
For most users facing standard 5 or 10-panel employment drug screens, kratom will not show up. Its alkaloids are pharmacologically distinct from the substances these panels are designed to detect, and no reliable cross-reactivity with opiate immunoassays has been documented. Specialized kratom-specific tests exist but are rarely deployed in routine workplace testing. Purchase from lab-tested sources likePureCraft CBD to ensure you know exactly what's in your products.
⚠ Important | Ehlers-Danlos syndrome is a complex connective tissue disorder requiring specialist management. CBD is not a treatment for EDS. Disc...
Read More
⚠ Important | Binge eating disorder is a serious psychiatric condition requiring clinical evaluation and evidence-based treatment — typically cogn...
Read More
⚠ Important | Secondary Raynaud's phenomenon is associated with underlying conditions (scleroderma, lupus, rheumatoid arthritis) that require phys...
Read More